Transepithelial transport of PEGylated anionic poly(amidoamine) dendrimers: Implications for oral drug delivery
- 1 August 2009
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 138 (1) , 78-85
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Potential Oral Delivery of 7-Ethyl-10-Hydroxy-Camptothecin (SN-38) using Poly(amidoamine) DendrimersPharmaceutical Research, 2008
- Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayersInternational Journal of Pharmaceutics, 2008
- Polymer platforms for drug delivery and biomedical imagingJournal of Controlled Release, 2007
- Molecular Dynamics Simulations of Charged Dendrimers: Low-to-Intermediate Half-Generation PAMAMsThe Journal of Physical Chemistry B, 2007
- PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing miceJournal of Controlled Release, 2006
- PAMAM Dendrimer-Based Multifunctional Conjugate for Cancer Therapy: Synthesis, Characterization, and FunctionalityBiomacromolecules, 2006
- Polymer conjugates: nanosized medicines for treating cancerTrends in Biotechnology, 2006
- NanomedicineClinical Pharmacokinetics, 2006
- Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complexAdvanced Drug Delivery Reviews, 2005
- The influence of surface modification on the cytotoxicity of PAMAM dendrimersInternational Journal of Pharmaceutics, 2003